These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1696367

  • 1. Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and choriocarcinoma of the placenta.
    Ollendorff DA, Goldberg JM, Abu-Jawdeh GM, Lurain JR.
    Obstet Gynecol; 1990 Sep; 76(3 Pt 2):494-7. PubMed ID: 1696367
    [Abstract] [Full Text] [Related]

  • 2. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP, Sikkema-Raddatz B, Beekhuis JR, De Wolf BT, Mantingh A.
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [Abstract] [Full Text] [Related]

  • 3. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM, Draper ML, Byrne JL, Ashwood EA, Lyon JL, Branch DW.
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [Abstract] [Full Text] [Related]

  • 4. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA.
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [Abstract] [Full Text] [Related]

  • 5. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.
    Burton BK.
    Obstet Gynecol; 1988 Nov; 72(5):709-13. PubMed ID: 2459638
    [Abstract] [Full Text] [Related]

  • 6. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S, Soncini E, Bonelli P, Piantelli G, Gramellini D.
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [Abstract] [Full Text] [Related]

  • 7. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC, Wolf EJ, Gould M, Macri CJ, Charnas LR.
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [Abstract] [Full Text] [Related]

  • 8. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Jul; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 9. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
    Killam WP, Miller RC, Seeds JW.
    Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441
    [Abstract] [Full Text] [Related]

  • 10. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
    Salim R, Okopnik M, Garmi G, Nachum Z, Zafran N, Shalev E.
    Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
    [Abstract] [Full Text] [Related]

  • 11. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
    Harper MA, Ruiz C, Pettenati MJ, Rao PN.
    Obstet Gynecol; 1994 May; 83(5 Pt 2):844-6. PubMed ID: 7512706
    [Abstract] [Full Text] [Related]

  • 12. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
    Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S.
    Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
    [Abstract] [Full Text] [Related]

  • 13. Unexplained positive/elevated maternal serum alpha-fetoprotein associated with placenta increta. A case report.
    McCool RA, Bombard AT, Bartholomew DA, Calhoun BC.
    J Reprod Med; 1992 Sep; 37(9):826-8. PubMed ID: 1280687
    [Abstract] [Full Text] [Related]

  • 14. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR, Lopes AM, Benn PA, Lerer T, Steinfeld JD, Ingardia CJ.
    J Matern Fetal Med; 2000 Sep; 9(3):161-4. PubMed ID: 10914623
    [Abstract] [Full Text] [Related]

  • 15. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
    Hong S, Berkowitz G, Wang W, Stone J, Ainbender E.
    Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
    [Abstract] [Full Text] [Related]

  • 16. Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
    Wax JR, Segna RA.
    J Matern Fetal Med; 1997 Sep; 6(6):338-40. PubMed ID: 9438217
    [Abstract] [Full Text] [Related]

  • 17. Choriocarcinoma in a term placenta: pathologic diagnosis of tumor in an asymptomatic patient with metastatic disease.
    Lage JM, Roberts DJ.
    Int J Gynecol Pathol; 1993 Jan; 12(1):80-5. PubMed ID: 8418082
    [Abstract] [Full Text] [Related]

  • 18. Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature.
    Liu J, Guo L.
    Gynecol Oncol; 2006 Dec; 103(3):1147-51. PubMed ID: 17005243
    [Abstract] [Full Text] [Related]

  • 19. Hereditary persistence of alpha-fetoprotein: a rare cause for unexplained alpha-fetoprotein elevations in pregnancy.
    Rood K, Stiller R.
    Conn Med; 2013 Jan; 77(1):43-5. PubMed ID: 23427373
    [Abstract] [Full Text] [Related]

  • 20. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
    Shumway JB, Greenspoon JS, Khouzami AN, Platt LD, Blakemore KJ.
    J Matern Fetal Med; 1996 Jan; 5(3):120-3. PubMed ID: 8796780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.